Evidence map›Paper›PMID 35577465›Full record

ArticleBMJ open2022

Strengthening Primary Healthcare through accelerated advancement of the global pharmacy workforce: a cross-sectional survey of 88 countries.

Ian Bates, Sherly Meilianti, Lina Bader, Rishi Gandhi, Rachael Leng, Kirsten Galbraith

Abstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ian BatesDepartment of Practice and Policy, Faculty of Life Sciences, UCL School of Pharmacy, London, UK.ORCID 0000-0003-2219-5171
Sherly MeiliantiDepartment of Practice and Policy, Faculty of Life Sciences, UCL School of Pharmacy, London, UK sherly.meilianti.15@ucl.ac.uk.ORCID 0000-0003-4023-0428
Lina BaderInternational Pharmaceutical Federation, The Hague, The Netherlands.
Rishi GandhiDepartment of Practice and Policy, Faculty of Life Sciences, UCL School of Pharmacy, London, UK.
Rachael LengDepartment of Practice and Policy, Faculty of Life Sciences, UCL School of Pharmacy, London, UK.
Kirsten GalbraithInternational Pharmaceutical Federation, The Hague, The Netherlands.ORCID 0000-0003-1703-8307

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdvancing the pharmacy workforce contributes to strengthening primary healthcare and accelerating progress towards universal health coverage. This study aimed to identify key enablers to support policy development for national pharmacy workforce advancement.

designA cross-sectional country-level questionnaire was distributed from July 2018 to March 2019.

settingNational-level or country-level pharmacy workforce development policy.

participantsProfessional leadership associations and national agencies of the International Pharmaceutical Federation (FIP). The FIP global database included 129 countries. MEASURES: The questionnaire was designed to collate data on the scope of advanced and specialist practice in respondent countries. Multiple correspondence analysis and subsequent cluster analysis were conducted to explore the associations and patterns of country-level attributes of systems in place for the pharmacy workforce advancement in order to develop a general transnational model for country-level advanced practice development.

resultsEighty-eight countries (68.2% response rate) responded to the questionnaire. Factors that enhance and contribute to advanced practice policy development include the country's socioeconomic factors and the availability of national practice advancement concepts. The essential advancement concepts include the availability of framework and professional recognition systems, programmes assisting advanced practice development and workforce advancement and recognition opportunities. Cluster analysis identified three clusters of country respondents. First cluster included low-income and middle-income with poor pharmacy advancement implementation, second cluster included a higher socioeconomic status with weaker pharmacy workforce advancement implementation and third cluster included upper middle-income to high-income countries and high rates of pharmacy advancement implementation.

conclusionThe key factors identified in this study can be used to support a transnational approach to pharmacy workforce advancement. The three clusters identified highlighted that workforce advancement was not an exclusive trait of higher-income countries. Lessons from countries that have already adopted concepts of advancement in pharmacy practice could be adopted to other countries to accelerate the progress of advanced practice globally.

Indexed as

PharmacistsPharmacyCross-Sectional StudiesHumansPrimary Health CareWorkforceeducation & training (see medical education & training)health policyprimary care

Identifiers

PMID35577465
PMCPMC9114847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.